{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,14]],"date-time":"2026-07-14T23:19:02Z","timestamp":1784071142016,"version":"3.55.0"},"reference-count":41,"publisher":"Public Library of Science (PLoS)","issue":"9","license":[{"start":{"date-parts":[[2020,9,11]],"date-time":"2020-09-11T00:00:00Z","timestamp":1599782400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100004513","name":"Harry Crossley Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100004513","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001323","name":"Poliomyelitis Research Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001323","id-type":"DOI","asserted-by":"publisher"}]},{"name":"National Health Laboratory Services"}],"content-domain":{"domain":["www.plosone.org"],"crossmark-restriction":false},"short-container-title":["PLoS ONE"],"DOI":"10.1371\/journal.pone.0238839","type":"journal-article","created":{"date-parts":[[2020,9,11]],"date-time":"2020-09-11T17:53:21Z","timestamp":1599846801000},"page":"e0238839","update-policy":"https:\/\/doi.org\/10.1371\/journal.pone.corrections_policy","source":"Crossref","is-referenced-by-count":5,"title":["Hepatitis B virus drug resistance mutations in HIV\/HBV co-infected children in Windhoek, Namibia"],"prefix":"10.1371","volume":"15","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-1609-7287","authenticated-orcid":true,"given":"Cynthia Raissa","family":"Tamandjou Tchuem","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laura","family":"Brandt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Etienne De la Rey","family":"Nel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2559-6034","authenticated-orcid":true,"given":"Mark Fredric","family":"Cotton","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Philippa","family":"Matthews","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Francina","family":"Kaindjee-Tjituka","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wolfgang","family":"Preiser","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Monique Ingrid","family":"Andersson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"340","published-online":{"date-parts":[[2020,9,11]]},"reference":[{"key":"pone.0238839.ref001","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1016\/j.jcv.2014.05.018","article-title":"Epidemiology and impact of HIV coinfection with hepatitis B and hepatitis C viruses in Sub-Saharan Africa","volume":"61","author":"PC Matthews","year":"2014","journal-title":"J Clin Virol"},{"key":"pone.0238839.ref002","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1097\/01.qai.0000233310.90484.16","article-title":"Mortality in the highly active antiretroviral therapy era: changing causes of death and disease in the HIV outpatient study","volume":"43","author":"FJ Palella","year":"2006","journal-title":"J Acquir Immune Defic Syndr"},{"key":"pone.0238839.ref003","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1016\/j.ijid.2014.07.018","article-title":"Impact of hepatitis B virus infection on HIV response to antiretroviral therapy in a Chinese antiretroviral therapy center","volume":"28","author":"R Yang","year":"2014","journal-title":"Int J Infect Dis"},{"key":"pone.0238839.ref004","doi-asserted-by":"crossref","first-page":"1026","DOI":"10.1089\/aid.2013.0004","article-title":"Liver stiffness is associated with monocyte activation in HIV-infected Ugandans without viral hepatitis","volume":"29","author":"AD Redd","year":"2013","journal-title":"AIDS Res Hum Retroviruses"},{"key":"pone.0238839.ref005","doi-asserted-by":"crossref","first-page":"2023","DOI":"10.1093\/carcin\/bgh207","article-title":"Pre-S mutant surface antigens in chronic hepatitis B virus infection induce oxidative stress and DNA damage","volume":"25","author":"YH Hsieh","year":"2004","journal-title":"Carcinogenesis"},{"key":"pone.0238839.ref006","doi-asserted-by":"crossref","first-page":"4509","DOI":"10.7314\/APJCP.2013.14.8.4509","article-title":"Hepatitis B Virus Gene Mutations and Hepatocarcinogenesis","volume":"14","author":"T Liang","year":"2013","journal-title":"Asian Pac J Cancer Prev"},{"key":"pone.0238839.ref007","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1016\/j.virusres.2016.10.002","article-title":"Higher prevalence of cancer related mutations 1762T\/1764A and PreS deletions in hepatitis B virus (HBV) isolated from HBV\/HIV co-infected compared to HBV-mono-infected Chinese adults","volume":"227","author":"KW Li","year":"2017","journal-title":"Virus Res"},{"key":"pone.0238839.ref008","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1053\/jhep.2001.21163","article-title":"Prevalence and significance of hepatitis B virus (HBV) pre\u2010S mutants in serum and liver at different replicative stages of chronic HBV infection","volume":"33","author":"YF Fan","year":"2001","journal-title":"Hepatology"},{"key":"pone.0238839.ref009","unstructured":"World Health Organization. Consolidated guidelines on the use of antiretroviral drugs for treating and preventing HIV infection. Available from: http:\/\/apps.who.int\/iris\/bitstream\/handle\/10665\/208825\/9789241549684_eng.pdf;jsessionid=356AC27853495106D6D92D46204A3891?sequence=1."},{"key":"pone.0238839.ref010","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1002\/hep.21020","article-title":"Long\u2010term lamivudine therapy for children with HBeAg\u2010positive chronic hepatitis B","volume":"43","author":"EM Sokal","year":"2006","journal-title":"Hepatology"},{"key":"pone.0238839.ref011","doi-asserted-by":"crossref","first-page":"1129","DOI":"10.1016\/S0140-6736(81)90585-7","article-title":"Hepatocellular Carcinoma and Hepatitis B Virus: A Prospective Study of 22 707","volume":"318","author":"RP Beasley","year":"1981","journal-title":"Men in Taiwan. The Lancet"},{"key":"pone.0238839.ref012","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1016\/S1386-6532(02)00049-5","article-title":"The virological and clinical significance of mutations in the overlapping envelope and polymerase genes of hepatitis B virus","volume":"25","author":"J Torresi","year":"2002","journal-title":"J Clin Virol"},{"key":"pone.0238839.ref013","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1016\/j.jcv.2016.10.017","article-title":"Screening, characterisation and prevention of Hepatitis B virus (HBV) co-infection in HIV-positive children in South Africa","volume":"85","author":"P jooste","year":"2016","journal-title":"J Clin Virol"},{"key":"pone.0238839.ref014","first-page":"464","article-title":"Pediatric HIV\u2013HBV Coinfection in Lusaka, Zambia: Prevalence and Short-Term Treatment Outcomes","volume":"61","author":"K Peebles","year":"2015","journal-title":"J Trop Pediatr"},{"key":"pone.0238839.ref015","unstructured":"Brandt L, Teferi T, Angala MP, Kalibbala M, Mendai R, Egodhi MM. Prevalence of HBV infection in HIV-infected children in northern Namibia; baseline ALT as an indicator of immune-tolerant HBV disease and selection of a lamivudine-sparing HAART regimen. [Abstract WEPE048]. In: 19th International AIDS (IAS) Conference, Washington, DC, July 22 to 27, 2012. Geneva, Switzerland: International AIDS Society; 1988"},{"key":"pone.0238839.ref016","doi-asserted-by":"crossref","first-page":"7604","DOI":"10.3748\/wjg.v22.i33.7604","article-title":"Dried blood spots, valid screening for viral hepatitis and human immunodeficiency virus in real-life","volume":"22","author":"BK M\u00f6ssner","year":"2016","journal-title":"World J Gastroenterol"},{"key":"pone.0238839.ref017","doi-asserted-by":"crossref","first-page":"1689","DOI":"10.3201\/eid1311.070578","article-title":"Non-A hepatitis B virus genotypes in antenatal clinics, United Kingdom","volume":"13","author":"S Dervisevic","year":"2007","journal-title":"Emerging Infect Dis"},{"key":"pone.0238839.ref018","doi-asserted-by":"crossref","first-page":"344","DOI":"10.1097\/MPG.0b013e3181aed725","article-title":"Performance of the AST-to-platelet ratio index as a noninvasive marker of fibrosis in pediatric patients with chronic viral hepatitis","volume":"50","author":"KE McGoogan","year":"2010","journal-title":"J Pediatr Gastroenterol Nutr"},{"key":"pone.0238839.ref019","doi-asserted-by":"crossref","first-page":"12309","DOI":"10.1038\/s41598-017-11489-2","article-title":"Prevalence and predictors of liver disease in HIV-infected children and adolescents","volume":"7","author":"M Pokorska-\u015apiewak","year":"2017","journal-title":"Sci Rep"},{"key":"pone.0238839.ref020","doi-asserted-by":"crossref","first-page":"1670","DOI":"10.1002\/hep.510270628","article-title":"Identification and characterization of mutations in hepatitis B virus resistant to lamivudine","volume":"27","author":"MI Allen","year":"1998","journal-title":"Hepatology"},{"key":"pone.0238839.ref021","doi-asserted-by":"crossref","first-page":"939","DOI":"10.1002\/hep.510290340","article-title":"YMDD motif in hepatitis B virus DNA polymerase influences on replication and lamivudine resistance: A study by in vitro full-length viral DNA transfection","volume":"29","author":"SK Ono-Nita","year":"1999","journal-title":"Hepatology"},{"key":"pone.0238839.ref022","doi-asserted-by":"crossref","first-page":"11833","DOI":"10.1128\/JVI.77.21.11833-11841.2003","article-title":"The Hepatitis B Virus Polymerase Mutation rtV173L Is Selected during Lamivudine Therapy and Enhances Viral Replication In Vitro","volume":"77","author":"WE Delaney","year":"2003","journal-title":"J Virol"},{"key":"pone.0238839.ref023","doi-asserted-by":"crossref","first-page":"2285","DOI":"10.1128\/AAC.01499-06","article-title":"The L80I substitution in the reverse transcriptase domain of the hepatitis B virus polymerase is associated with lamivudine resistance and enhanced viral replication in vitro","volume":"51","author":"N Warner","year":"2007","journal-title":"Antimicrob Agents Chemother"},{"key":"pone.0238839.ref024","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1186\/1743-422X-10-313","article-title":"Profile of hepatitis B virus resistance mutations against nucleoside\/nucleotide analogue treatment in Chinese patients with chronic hepatitis B","volume":"10","author":"J Lei","year":"2013","journal-title":"Virol J"},{"key":"pone.0238839.ref025","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1016\/j.virol.2016.11.007","article-title":"Stop codons in the hepatitis B surface proteins are enriched during antiviral therapy and are associated with host cell apoptosis","volume":"501","author":"D Colledge","year":"2017","journal-title":"Virology"},{"key":"pone.0238839.ref026","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1016\/j.jhep.2011.06.028","article-title":"Nucleotide change of codon 182 in the surface gene of hepatitis B virus genotype C leading to truncated surface protein is associated with progression of liver diseases","volume":"56","author":"SA Lee","year":"2012","journal-title":"J Hepatol"},{"key":"pone.0238839.ref027","doi-asserted-by":"crossref","first-page":"901","DOI":"10.1099\/vir.0.83468-0","article-title":"Effect of basal core promoter and pre-core mutations on hepatitis B virus replication","volume":"89","author":"S Jammeh","year":"2008","journal-title":"J Gen Virol"},{"key":"pone.0238839.ref028","doi-asserted-by":"crossref","first-page":"753","DOI":"10.1111\/j.1365-2893.2008.00998.x","article-title":"Clinical significance of precore and core promoter mutations in genotype D hepatitis B-related chronic liver disease","volume":"15","author":"H Poustchi","year":"2008","journal-title":"J Viral Hepat"},{"key":"pone.0238839.ref029","doi-asserted-by":"crossref","first-page":"31","DOI":"10.18869\/acadpub.mlj.10.1.31","article-title":"Mutations at Nucleotide 1762, 1764 and 1766 of Hepatitis B Virus X Gene in Patients with Chronic Hepatitis B and Hepatitis B-Related Cirrhosis","volume":"10","author":"F Salarneia","year":"2016","journal-title":"Med Lab J"},{"key":"pone.0238839.ref030","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1016\/j.cmi.2015.10.033","article-title":"Hepatitis B virus basal core promoter\/precore mutants and association with liver cirrhosis in children with chronic hepatitis B virus infection","volume":"22","author":"YW Zhong","year":"2016","journal-title":"Clin Microbiol Infect"},{"key":"pone.0238839.ref031","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1001\/jama.295.1.65","article-title":"Risk of Hepatocellular Carcinoma Across a Biological Gradient of Serum Hepatitis B Virus DNA Level","volume":"295","author":"C-J Chen","year":"2006","journal-title":"JAMA"},{"key":"pone.0238839.ref032","doi-asserted-by":"crossref","first-page":"678","DOI":"10.1053\/j.gastro.2005.11.016","article-title":"Predicting Cirrhosis Risk Based on the Level of Circulating Hepatitis B Viral Load","volume":"130","author":"UH Iloeje","year":"2006","journal-title":"Gastroenterology"},{"key":"pone.0238839.ref033","unstructured":"World Health Organization. Guidelines for the prevention, care and treatment of persons with chronic hepatitis B infection. Available from: https:\/\/apps.who.int\/iris\/bitstream\/handle\/10665\/154590\/9789241549059_eng.pdf;jsessionid=22A87E133D9E393FCEA257A881DBA2A4?sequence=1."},{"key":"pone.0238839.ref034","unstructured":"Ministry of Health and Social Services. National Guidelines for Antiretroviral Therapy. Directorate of Special Programmes. Available from: http:\/\/www.mhss.gov.na\/documents\/119527\/364677\/National+Guidelines+for+Antiretroviral+Therapy+2014.pdf\/66bf6603-7640-418b-b464-442b1e8b2c91."},{"key":"pone.0238839.ref035","unstructured":"Ministry of Health and Social Services. National Guidelines for Antiretroviral Therapy. Directorate of Special Programmes, 2016. Available from: http:\/\/92.222.142.204\/Portals\/0\/adam\/Content\/VVys6XEqAkiCUujlnxr3qA\/File\/na_national_guidelines_art.pdf."},{"key":"pone.0238839.ref036","doi-asserted-by":"crossref","first-page":"882","DOI":"10.1128\/AAC.01061-09","article-title":"Mechanism of entecavir resistance of hepatitis B virus with viral breakthrough as determined by long-term clinical assessment and molecular docking simulation","volume":"54","author":"M Mukaide","year":"2010","journal-title":"Antimicrob Agents Chemother"},{"key":"pone.0238839.ref037","doi-asserted-by":"crossref","first-page":"1779","DOI":"10.1097\/QAD.0b013e32830b3ab5","article-title":"Efficacy and safety of entecavir for chronic HBV in HIV\/HBV coinfected patients receiving lamivudine as part of antiretroviral therapy","volume":"22","author":"MG Pess\u00f4a","year":"2008","journal-title":"AIDS"},{"key":"pone.0238839.ref038","doi-asserted-by":"crossref","first-page":"e0169228","DOI":"10.1371\/journal.pone.0169228","article-title":"Virological Response to Tenofovir Disoproxil Fumarate in HIV-Positive Patients with Lamivudine-Resistant Hepatitis B Virus Coinfection in an Area Hyperendemic for Hepatitis B Virus Infection","volume":"11","author":"YS Huang","year":"2016","journal-title":"PLoS One"},{"key":"pone.0238839.ref039","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1097\/INF.0000000000001491","article-title":"Response to Tenofovir Among Lamivudine-Experienced Hepatitis B and HIV Coinfected Adolescents","volume":"36","author":"L Aurpibul","year":"2017","journal-title":"Pediatr Infect Dis J"},{"key":"pone.0238839.ref040","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1080\/14656566.2018.1559299","article-title":"An evaluation of elvitegravir plus cobicistat plus tenofovir alafenamide plus emtricitabine as a single-tablet regimen for the treatment of HIV in children and adolescents","volume":"20","author":"V Giacomet","year":"2019","journal-title":"Expert Opin Pharmacother"},{"key":"pone.0238839.ref041","unstructured":"Gaur A, Cotton M, Rodriguez C. Bictegravir\/FTC\/TAF single-tablet regimen in adolescents and children: week 48 results. [Abstract 46]. In: 26th Conference on Retroviruses and opportunistic infections (CROI), Seattle, Washington, March 4 to 7 2019. San Francisco, CA: International Antiviral Society\u2013USA; 1992."}],"container-title":["PLOS ONE"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0238839","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,9,11]],"date-time":"2020-09-11T17:53:45Z","timestamp":1599846825000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0238839"}},"subtitle":[],"editor":[{"given":"Luis","family":"Men\u00e9ndez-Arias","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]}],"short-title":[],"issued":{"date-parts":[[2020,9,11]]},"references-count":41,"journal-issue":{"issue":"9","published-online":{"date-parts":[[2020,9,11]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pone.0238839","relation":{},"ISSN":["1932-6203"],"issn-type":[{"value":"1932-6203","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,9,11]]}}}